Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Brandywine Pharmaceuticals, LLC recalls Theophylline Extended-Release Tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory
Products
  • Theophylline Extended-Release Tablets
Where it was sold

Nationwide within U.S

Nationwide

Units affected
1,620 100-count bottles
About this recall
Theophylline Extended-Release Tablets, 100 mg, Rx Only, 100-count bottle, Distributed by: Brandywine Pharmaceuticals, LLC, West Chester, PA 19382, NDC: 71321-500-10